Charles River Laboratories International (CRL) Curent Deferred Tax Liability (2010 - 2011)
Charles River Laboratories International (CRL) posted Curent Deferred Tax Liability of $1.1 million for Q3 2011, down 3.95% on a QoQ basis from $1.1 million in Q2 2011.
Analysis
Charles River Laboratories International (CRL) Curent Deferred Tax Liability (2010 - 2011) Analysis & Trends
Charles River Laboratories International has reported Curent Deferred Tax Liability for 2 years, with the latest figure at $1.1 million in Q3 2011.
- On a quarterly basis, Curent Deferred Tax Liability changed N/A year-over-year to $1.1 million in Q3 2011; TTM through Sep 2011 was $1.1 million, a N/A change from a year earlier, with the FY2010 full-year figure at $963000.0, changed N/A from the prior year.
- Curent Deferred Tax Liability was $1.1 million for Q3 2011 at Charles River Laboratories International, down from $1.1 million in the prior quarter.
- The five-year high for Curent Deferred Tax Liability was $1.1 million in Q2 2011, with the low at $963000.0 in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 8.22 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 24, 2011 | 1.07 Mn |
| Jun 25, 2011 | 1.12 Mn |
| Dec 25, 2010 | 963,000.00 |